Skip to main content

Table 1 Activity measured on different parts of the cassette immediately after synthesis on MLPT (n = 3)

From: Fully-automated production of [68Ga]Ga-FAPI-46 for clinical application

load [μg]

product vial [%]

CM cartridge [%]

waste [%]

SCX cartridge [%]

reaction vial [%]

RCY [%]

10

70.2 ± 6.1

26.2 ± 6.1

1.5 ± 1.0

0.6 ± 0.1

1.5 ± 0.3

68.9 ± 3.8

20

91.5 ± 1.9

4.8 ± 0.8

2.1 ± 1.5

0.6 ± 0.3

1.0 ± 0.3

91.8 ± 3.9

30

95.1 ± 0.4

2.9 ± 0.3

0.4 ± 0.2

0.4 ± 0.1

1.1 ± 0.4

94.2 ± 0.8

40

95.3 ± 1.2

2.7 ± 0.9

0.6 ± 0.1

0.3 ± 0.0

1.1 ± 0.3

95.1 ± 2.1

50

96.0 ± 0.6

2.1 ± 0.8

0.5 ± 0.1

0.5 ± 0.2

0.9 ± 0.2

95.2 ± 1.4